Ізраїль - іврит - Ministry of Health

taro international ltd, israel - dasatinib - טבליות מצופות פילם - dasatinib 50 mg - dasatinib

Ізраїль - іврит - Ministry of Health

taro international ltd, israel - dasatinib - טבליות מצופות פילם - dasatinib 70 mg - dasatinib

Ізраїль - іврит - Ministry of Health

taro international ltd, israel - dasatinib - טבליות מצופות פילם - dasatinib 80 mg - dasatinib

Ізраїль - іврит - Ministry of Health

astrazeneca (israel) ltd - budesonide micronized; formoterol fumarate - אבקה לשאיפה - budesonide micronized 160 mcg/dose; formoterol fumarate 4.5 mcg/dose - formoterol and budesonide - formoterol and other drugs for obstructive airway diseases - asthma symbicort turbuhaler is indicated in the regular treatment of asthma in adults and adolescents age 12 years and above where use of a combination (inhaled corticosteroid and long acting beta-agonist) is appropriate: - patients not adequately controlled with inhaled corticosteroids and " as needed" inhaled short acting beta2- agonists. or - patients already adequately controlled on both inhaled corticosteroids and long acting beta2- agonists. copd symptomatic treatment of patients with severe copd (fev1 < 50 % predicted normal) and a history of repeated exacerbations who have significant symptoms despite regular therapy with long-acting bronchodilators.

Ізраїль - іврит - Ministry of Health

astrazeneca (israel) ltd - budesonide micronized; formoterol fumarate - אבקה לשאיפה - budesonide micronized 80 mcg/dose; formoterol fumarate 4.5 mcg/dose - formoterol and budesonide - formoterol and other drugs for obstructive airway diseases - symbicort turbuhaler is indicated in the regular treatment of asthma where use of a combination (inhaled corticosteroid and long acting beta-agonist) is appropriate: - patients not adequaterly controlled with inhaled corticosteroids and " as needed" inhaled short acting beta2- agonists. - or patients already adequately controlled on both inhaled corticosteroids and long acting beta2- agonists. note: symbicort turbuhaler 80/4.5 mcg/dose is not appropriate in patients with severe asthma.

Ізраїль - іврит - Ministry of Health

תרופארם שיווק 1985 בע"מ - רופא - ספוג קולגן מצופה גנטמיצין למניעת זיהומים.

Ізраїль - іврит - Ministry of Health

כצט בע"מ - רופא - יריעת קולגן המשמשת למניעת הדבקות לאחר ניתוחים שונים כגון : ניתוחים במערכת העיכול, ניתוחים כלליים, ניתוחים גנקולוגיים ואורולוגיים.

Ізраїль - іврит - Ministry of Health

astrazeneca (israel) ltd - budesonide micronized; formoterol fumarate - אבקה לשאיפה - budesonide micronized 320 mcg/dose; formoterol fumarate 9 mcg/dose - formoterol and budesonide - formoterol and other drugs for obstructive airway diseases - symbicort turbuhaler is indicated in the regular treatment of asthma in adults and adolescents (over the age of 12 years) where use of a combination (inhaled corticosteroid and long acting beta-agonist) is appropriate: - patients not adequaterly controlled with inhaled corticosteroids and " as needed" inhaled short acting beta2- agonists. - or patients already adequately controlled on both inhaled corticosteroids and long acting beta2- agonists. copd symptomatic treatment of patients with severe copd (fev1 < 50 % predicted normal) and a history of repeated exacerbations who have significant symptoms despite regular therapy with long-acting bronchodilators.

Ізраїль - іврит - Ministry of Health

beammed ltd. - מומחה - מכשיר לטיפול בצלוליטיס והצרת היקפים

Ізраїль - іврит - Ministry of Health

סינרון ביוטי בע"מ - כלל האוכלוסיה - מיועד להלבנת שיניים